Patents by Inventor Tetsuya Asari

Tetsuya Asari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical Composition for Prevention or Treatment of Disease Associated with Tear Reduction
    Publication number: 20110092509
    Abstract: The present invention provides pharmaceutical compositions for the prevention or treatment of diseases associated with decrease in tear.
    Type: Application
    Filed: August 7, 2009
    Publication date: April 21, 2011
    Applicant: Kissei Pharmaceutical, Co. Ltd.
    Inventors: Mamoru Kobayashi, Tetsuya Asari, Mariko Tadachi
  • Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid
    Publication number: 20100197788
    Abstract: The present invention provides pharmaceuticals for the prevention or treatment of diseases associated with decrease in tear. That is, the present invention provides pharmaceuticals for the prevention or treatment of diseases associated with decrease in tear such as dry eye, dry disorders of cornea and conjunctiva, disorders of the keratoconjunctival epithelium, syndrome with decrease in tear secretion, xerophthalmia, dry eye due to aging, opthalmopathy in Stevens-Johnson syndrome, opthalmopathy in Sjögren's syndrome, keratoconjunctival ulcer, dryness in wearing of contact lens or the like, which comprises a ?3 adrenoceptor stimulant. The present invention also provides a combination pharmaceutical comprising a ?3 adrenoceptor stimulant and a ?2 adrenoceptor stimulant.
    Type: Application
    Filed: February 19, 2008
    Publication date: August 5, 2010
    Inventors: Mamoru Kobayashi, Tetsuya Asari
  • Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid
    Publication number: 20080306160
    Abstract: The present invention provides pharmaceuticals for the prevention or treatment of diseases associated with decrease in tear. That is, the present invention provides pharmaceuticals for the prevention or treatment of diseases associated with decrease in tear such as dry eye, dry disorders of cornea and conjunctiva, disorders of the keratoconjunctival epithelium, syndrome with decrease in tear secretion, xerophthalmia, dry eye due to aging, opthalmopathy in Stevens-Johnson syndrome, opthalmopathy in Sjögren's syndrome, keratoconjunctival ulcer, dryness in wearing of contact lens or the like, which comprises a ?3 adrenoceptor stimulant. The present invention also provides a combination pharmaceutical comprising a ?3 adrenoceptor stimulant and a ?2 adrenoceptor stimulant.
    Type: Application
    Filed: February 19, 2008
    Publication date: December 11, 2008
    Inventors: Mamoru Kobayashi, Tetsuya Asari